ATE231167T1 - Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper - Google Patents
Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörperInfo
- Publication number
- ATE231167T1 ATE231167T1 AT95941870T AT95941870T ATE231167T1 AT E231167 T1 ATE231167 T1 AT E231167T1 AT 95941870 T AT95941870 T AT 95941870T AT 95941870 T AT95941870 T AT 95941870T AT E231167 T1 ATE231167 T1 AT E231167T1
- Authority
- AT
- Austria
- Prior art keywords
- thymidine phosphorylase
- human
- monoclonal antibody
- growth factor
- cell growth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
- G01N2474/20—Immunohistochemistry assay
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32732894A JP3268147B2 (ja) | 1994-12-28 | 1994-12-28 | モノクローナル抗体 |
PCT/JP1995/002661 WO1996020217A1 (fr) | 1994-12-28 | 1995-12-25 | Anticorps monoclonal |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE231167T1 true ATE231167T1 (de) | 2003-02-15 |
Family
ID=18197918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95941870T ATE231167T1 (de) | 1994-12-28 | 1995-12-25 | Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper |
Country Status (8)
Country | Link |
---|---|
US (1) | US5798213A (de) |
EP (1) | EP0749981B1 (de) |
JP (1) | JP3268147B2 (de) |
AT (1) | ATE231167T1 (de) |
AU (1) | AU4315396A (de) |
DE (1) | DE69529405T2 (de) |
ES (1) | ES2191722T3 (de) |
WO (1) | WO1996020217A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003025575A1 (en) * | 2001-09-17 | 2003-03-27 | Board Of Regents, The University Of Texas System | Methods and compositions involving thymidine phosphorylase as a marker for hiv infection, aids progression, and drug resistance |
EP3067698A1 (de) * | 2015-03-11 | 2016-09-14 | Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) | Pd-ecgf als biomarker für krebs |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5227302A (en) * | 1988-12-20 | 1993-07-13 | Ludwig Institute For Cancer Research | DNA encoding platelet derived endothelial cell growth factor (PD-ECGF) |
CA2005600A1 (en) * | 1988-12-20 | 1990-06-20 | Cal-Henrik Heldin | Endothelial cell growth factor |
-
1994
- 1994-12-28 JP JP32732894A patent/JP3268147B2/ja not_active Expired - Lifetime
-
1995
- 1995-12-25 AT AT95941870T patent/ATE231167T1/de not_active IP Right Cessation
- 1995-12-25 AU AU43153/96A patent/AU4315396A/en not_active Abandoned
- 1995-12-25 WO PCT/JP1995/002661 patent/WO1996020217A1/ja active IP Right Grant
- 1995-12-25 DE DE69529405T patent/DE69529405T2/de not_active Expired - Lifetime
- 1995-12-25 US US08/696,827 patent/US5798213A/en not_active Expired - Lifetime
- 1995-12-25 ES ES95941870T patent/ES2191722T3/es not_active Expired - Lifetime
- 1995-12-25 EP EP95941870A patent/EP0749981B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69529405T2 (de) | 2003-10-30 |
JP3268147B2 (ja) | 2002-03-25 |
DE69529405D1 (en) | 2003-02-20 |
EP0749981A4 (de) | 2000-03-08 |
EP0749981A1 (de) | 1996-12-27 |
JPH08183800A (ja) | 1996-07-16 |
US5798213A (en) | 1998-08-25 |
AU4315396A (en) | 1996-07-19 |
EP0749981B1 (de) | 2003-01-15 |
WO1996020217A1 (fr) | 1996-07-04 |
ES2191722T3 (es) | 2003-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4636463A (en) | Antibodies to human interleukin-2 induced by synthetic polypeptides | |
GR3036906T3 (en) | Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof. | |
NO20074516L (no) | Pattedyrcytokinlignende polypeptid-1 | |
ATE366747T1 (de) | Menschliche monoklonale antikörper gegen den epidermalen wachstumsfaktorrezeptor | |
FR12C0004I2 (fr) | Anticorps contre l'antigene ctla-4 humain et utilisation | |
ATE295414T1 (de) | Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen | |
ATE159727T1 (de) | Kleinste erkennungseinheit eines pem-mucin- ''tandem repeat''-spezifischen monoklonalen antikoerpers | |
ATE223229T1 (de) | Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren | |
DE69309906T2 (de) | Behandlung für entzündungserkrankung des darmes | |
FI944509A (fi) | Interferonireseptorin vastaisia monoklonaalisia vasta-aineita, joilla on neutralisoivaa aktiivisuutta tyypin I interferonia vastaan | |
ATE112783T1 (de) | Stressprotein aus bakterien. | |
FR2660757B1 (fr) | Procede d'identification ou de dosage de proteines et applications. | |
CA2126182A1 (en) | Humanized antibodies reactive with gpiib/iiia | |
DE69216600D1 (de) | Synthetisches CDw52(CAMPATH-1) Peptidantigen | |
FI925321A0 (fi) | Immunodiagnostiskt ledinflammationstest | |
ATE230418T1 (de) | Monoklonaler antikörper gegen das humane mx- protein mxa | |
ATE231167T1 (de) | Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper | |
KR890016165A (ko) | 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도 | |
FR2571146B1 (fr) | Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant | |
DE3580524D1 (de) | Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen. | |
FR2718849B1 (fr) | Procédé d'immunodosage de l'antithrombine III activée par un glycosaminoglycane, anticorps monoclonaux correspondants et leur procédé d'obtention. | |
DE69332583D1 (de) | Maspin- ein neues serpin mit tumor unterdrückender aktivität | |
US4771125A (en) | Human soluble immune response suppressor | |
TH13774EX (th) | รีคอมบิแนนท์แอนติบอดีสำหรับการรักษาโรคมนุษย์ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0749981 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |